Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ajinomoto CELLiST is a leading provider of animal cell culture media and contract manufacturing services for the biopharmaceutical industry. The company leverages over 30 years of expertise in amino acid technology to supply high-quality basal and feed media for CHO and HEK293 cell lines. Its products are used globally to support the development and manufacture of monoclonal antibodies, recombinant proteins, biosimilars, vaccines, and other biologic drugs. The company's facilities are GMP-compliant. No clinical results apply as it is not a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ajinomoto CELLiST.